These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fine specificity of class I MHC recognition in islet allografts. Ferguson D; Kohli N; Munn SR Transplant Proc; 1995 Dec; 27(6):3222. PubMed ID: 8539924 [No Abstract] [Full Text] [Related]
5. [Current status on transplantation of the endocrine pancreas in the treatment of diabetes mellitus. I. Transplantation of the islands of Langerhans]. Santini A; Riccipetitoni G; Morsiani E; Durante E Minerva Med; 1979 Jul; 70(33):2295-307. PubMed ID: 111164 [No Abstract] [Full Text] [Related]
6. Nature of tolerance induction to peripheral (extrathymic) islet allografts. Coulombe M; Lafferty KJ; Gill RG Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624 [No Abstract] [Full Text] [Related]
8. Investigations of the viability and immunogenicity of fetal pancreas islet tissue. Kirste G; Wilms H; Freudenberg N Transplant Proc; 1989 Feb; 21(1 Pt 3):2673. PubMed ID: 2495665 [No Abstract] [Full Text] [Related]
9. Control of alloxan diabetes in dogs by islet cell transplantation. Pemberton LB; Manax WG Surg Gynecol Obstet; 1971 Jan; 132(1):75-80. PubMed ID: 4992381 [No Abstract] [Full Text] [Related]
10. Current status of experimental islet transplantation. Lafferty KJ; Prowse SJ; Simeonovic CJ; Hegre O; Chase HP Transplant Proc; 1984 Jun; 16(3):813-9. PubMed ID: 6428005 [No Abstract] [Full Text] [Related]
11. Pancreatic islet transplantation across partial major histocompatibility complex barriers. Georgiou HM; Mandel TE Transplant Proc; 1985 Apr; 17(2):1723-7. PubMed ID: 3920798 [No Abstract] [Full Text] [Related]
12. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy. Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395 [TBL] [Abstract][Full Text] [Related]
13. Permanent acceptance of mitomycin C-treated islet allograft. Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788 [TBL] [Abstract][Full Text] [Related]
14. [Potentials of transplantation treatment in experimental and clinical diabetes mellitus (a review of the literature)]. Smirnov VV; Martynova MI; Mentkevich GL Vopr Okhr Materin Det; 1980 Jul; 25(7):26-30. PubMed ID: 6774476 [No Abstract] [Full Text] [Related]
15. Prevention of early loss of transplanted islets in the liver of mice by adenosine. Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680 [TBL] [Abstract][Full Text] [Related]
16. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells. Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304 [No Abstract] [Full Text] [Related]
17. A fibrin gel carrier system for islet transplantation into kidney subcapsule. Lim JY; Min BH; Kim BG; Han HJ; Kim SJ; Kim CW; Han SS; Shin JS Acta Diabetol; 2009 Sep; 46(3):243-8. PubMed ID: 19030773 [TBL] [Abstract][Full Text] [Related]
18. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts. Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081 [TBL] [Abstract][Full Text] [Related]
19. Influence of islet mass and purity on reversibility of diabetes in pancreatectomized pigs. Mellert J; Hopt UT; Hering BJ; Bretzel RG; Federlin K Transplant Proc; 1991 Feb; 23(1 Pt 2):1687-9. PubMed ID: 1989331 [No Abstract] [Full Text] [Related]